Elicio Therapeutics, Inc. (ELTX)
ELTX Stock Price Chart
Explore Elicio Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze ELTX price movements and trends.
ELTX Company Profile
Discover essential business fundamentals and corporate details for Elicio Therapeutics, Inc. (ELTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 Feb 2021
Employees
32.00
Website
https://elicio.comCEO
Robert T. Connelly
Description
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.
ELTX Financial Timeline
Browse a chronological timeline of Elicio Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.62.
Earnings released on 7 Aug 2025
EPS came in at -$0.66 surpassing the estimated -$0.69 by +4.35%.
Earnings released on 13 May 2025
EPS came in at -$0.87 falling short of the estimated -$0.67 by -29.85%.
Earnings released on 31 Mar 2025
EPS came in at -$1.02 falling short of the estimated -$0.94 by -8.51%, while revenue for the quarter reached $1.17M .
Earnings released on 13 Nov 2024
EPS came in at -$1.39 falling short of the estimated -$0.81 by -71.60%.
Earnings released on 13 Aug 2024
EPS came in at -$0.64 surpassing the estimated -$0.96 by +33.33%.
Earnings released on 15 May 2024
EPS came in at -$1.15 falling short of the estimated -$1.09 by -5.50%.
Earnings released on 13 Feb 2024
EPS came in at -$1.75 falling short of the estimated -$0.78 by -124.36%.
Earnings released on 9 Nov 2023
EPS came in at -$1.27 falling short of the estimated -$0.80 by -58.75%.
Earnings released on 11 Aug 2023
EPS came in at -$2.61 surpassing the estimated -$5.70 by +54.21%.
Stock split effective on 2 Jun 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 May 2023
EPS came in at -$0.15 surpassing the estimated -$0.54 by +72.22%.
Earnings released on 31 Dec 2022
EPS came in at -$2.15 .
Earnings released on 30 Sept 2022
EPS came in at -$2.27 surpassing the estimated -$3.20 by +29.16%.
Earnings released on 30 Jun 2022
EPS came in at -$2.37 surpassing the estimated -$4.63 by +48.94%, while revenue for the quarter reached $653.00K , missing expectations by -51.63%.
Earnings released on 31 Mar 2022
EPS came in at -$4.75 , while revenue for the quarter reached $1.65M .
Earnings released on 31 Dec 2021
EPS came in at $4.97 , while revenue for the quarter reached $25.94M .
Earnings released on 29 Sept 2021
EPS came in at -$5.26 , while revenue for the quarter reached $1.46M .
Earnings released on 30 Jun 2021
EPS came in at -$5.75 , while revenue for the quarter reached $540.00K .
Earnings released on 31 Mar 2021
EPS came in at -$0.47 .
Earnings released on 31 Dec 2020
EPS came in at -$3.87 , while revenue for the quarter reached $459.00K .
Earnings released on 30 Sept 2020
EPS came in at -$2.37 , while revenue for the quarter reached $827.00K .
ELTX Stock Performance
Access detailed ELTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.